Literature DB >> 28547819

The impact of serum incubation time on IgM/IgG binding to porcine aortic endothelial cells.

Zhongqiang Zhang1,2, Bingsi Gao2, Chengjiang Zhao3, Cassandra Long2, Haizhi Qi1, Mohamed Ezzelarab2, David Kc Cooper2, Hidetaka Hara2.   

Abstract

The results of the assay for measuring anti-non-Gal antibodies (which affect pig xenograft survival) in recipients are important. Serum incubation time and concentration may be important factors in the extent of antibody binding to the graft. The aim of this in vitro study was to determine the optimal incubation time and serum concentration for measuring anti-non-Gal antibody binding to porcine aortic endothelial cells (pAECs). Pooled human, naive, and sensitized baboon sera were incubated with wild-type, α1,3-galactosyltransferase gene-knockout (GTKO), and GTKO/human CD55 pAECs. IgM/IgG binding to pAECs after varying serum incubation times (0.5, 1, 2, and 3 hour) and concentrations (5, 10, 20, and 40 μL) was determined by flow cytometry. An increase in incubation time from 30 minutes to 2 hour was associated with increases in anti-non-Gal IgM/IgG binding to GTKO and GTKO/hCD55 pAECs of pooled human, naive and sensitized baboon sera (P<.05). Pooled human serum showed a significant increase in anti-non-Gal IgM (1.5 times) and a minimal increase in anti-non-Gal IgG antibody binding. IgM/IgG binding of sensitized baboon serum to GTKO pAECs after 2-hour incubation was 1.5 times and 2 times greater than after 30-minutes incubation, respectively, whereas naïve baboon sera showed minimal (non-significant) increase in anti-non-Gal IgM/IgG antibody binding. With 2-hour incubation, increasing the serum concentration from 5 μL to 20 μL significantly increased antibody binding to non-Gal antigens in pooled human and sensitized baboon serum. With naïve baboon serum, only IgG was significantly increased. Increasing the serum incubation time contributed to improve the sensitivity of detecting anti-non-Gal antibodies, without affecting cell viability in vitro.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Xenotransplantation; anti-non-Gal; antibodies; baboon; human; porcine aortic endothelial cells; α1,3-galactosyltransferase gene-knockout

Mesh:

Substances:

Year:  2017        PMID: 28547819      PMCID: PMC5546950          DOI: 10.1111/xen.12312

Source DB:  PubMed          Journal:  Xenotransplantation        ISSN: 0908-665X            Impact factor:   3.907


  38 in total

1.  Evaluation of human and non-human primate antibody binding to pig cells lacking GGTA1/CMAH/β4GalNT2 genes.

Authors:  Jose L Estrada; Greg Martens; Ping Li; Andrew Adams; Kenneth A Newell; Mandy L Ford; James R Butler; Richard Sidner; Matt Tector; Joseph Tector
Journal:  Xenotransplantation       Date:  2015-03-01       Impact factor: 3.907

2.  Immunogenicity of Renal Microvascular Endothelial Cells From Genetically Modified Pigs.

Authors:  Zheng-Yu Wang; Ping Li; James R Butler; Ross L Blankenship; Susan M Downey; Jessica B Montgomery; Shunji Nagai; Jose L Estrada; Matthew F Tector; A Joseph Tector
Journal:  Transplantation       Date:  2016-03       Impact factor: 4.939

3.  Silencing porcine genes significantly reduces human-anti-pig cytotoxicity profiles: an alternative to direct complement regulation.

Authors:  James R Butler; Gregory R Martens; Jose L Estrada; Luz M Reyes; Joseph M Ladowski; Cesare Galli; Andrea Perota; Conor M Cunningham; Matthew Tector; A Joseph Tector
Journal:  Transgenic Res       Date:  2016-04-21       Impact factor: 2.788

4.  Erythrocytes from GGTA1/CMAH knockout pigs: implications for xenotransfusion and testing in non-human primates.

Authors:  Zheng-Yu Wang; Christopher Burlak; Jose L Estrada; Ping Li; Matthew F Tector; A Joseph Tector
Journal:  Xenotransplantation       Date:  2014-07-02       Impact factor: 3.907

5.  Reduced binding of human antibodies to cells from GGTA1/CMAH KO pigs.

Authors:  C Burlak; L L Paris; A J Lutz; R A Sidner; J Estrada; P Li; M Tector; A J Tector
Journal:  Am J Transplant       Date:  2014-06-06       Impact factor: 8.086

6.  Potential value of human thrombomodulin and DAF expression for coagulation control in pig-to-human xenotransplantation.

Authors:  Yuko Miwa; Koji Yamamoto; Akira Onishi; Masaki Iwamoto; Satoko Yazaki; Masataka Haneda; Kenta Iwasaki; DaGe Liu; Haruko Ogawa; Takaharu Nagasaka; Kazuharu Uchida; Akimasa Nakao; Kenji Kadomatsu; Takaaki Kobayashi
Journal:  Xenotransplantation       Date:  2010 Jan-Feb       Impact factor: 3.907

7.  Costimulation blockade in pig artery patch xenotransplantation - a simple model to monitor the adaptive immune response in nonhuman primates.

Authors:  Mohamed B Ezzelarab; Burcin Ekser; Gabriel Echeverri; Hidetaka Hara; Corin Ezzelarab; Cassandra Long; Pietro Bajona; Bertha Garcia; Noriko Murase; David Ayares; David K C Cooper
Journal:  Xenotransplantation       Date:  2012 Jul-Aug       Impact factor: 3.907

8.  Resistance to anti-xenogeneic response by combining alpha-Gal silencing with HO-1 upregulation.

Authors:  Min Zhu; Wei Zhang; Fang Liu; Lu Wang; Bin Liu; Dong Chen; Xue-Hai Zhu; Wei-Jie Zhang; Thomas E Ichim; Zhi-Shui Chen; Ping Zhou; Shi Chen; Gang Chen
Journal:  Transpl Immunol       Date:  2008-07-01       Impact factor: 1.708

9.  Eliminating Xenoantigen Expression on Swine RBC.

Authors:  Zheng-Yu Wang; Gregory R Martens; Ross L Blankenship; Richard A Sidner; Ping Li; Jose L Estrada; Matthew Tector; A Joseph Tector
Journal:  Transplantation       Date:  2017-03       Impact factor: 4.939

10.  Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO.hCD46.hTBM pig-to-primate cardiac xenograft.

Authors:  Muhammad M Mohiuddin; Avneesh K Singh; Philip C Corcoran; Marvin L Thomas Iii; Tannia Clark; Billeta G Lewis; Robert F Hoyt; Michael Eckhaus; Richard N Pierson Iii; Aaron J Belli; Eckhard Wolf; Nikolai Klymiuk; Carol Phelps; Keith A Reimann; David Ayares; Keith A Horvath
Journal:  Nat Commun       Date:  2016-04-05       Impact factor: 14.919

View more
  2 in total

1.  B cell phenotypes in baboons with pig artery patch grafts receiving conventional immunosuppressive therapy.

Authors:  Takayuki Yamamoto; Qi Li; Hidetaka Hara; Liaoran Wang; Hongmin Zhou; Juan Li; Devin E Eckhoff; A Joseph Tector; Edwin C Klein; Ray Lovingood; Mohamed Ezzelarab; David Ayares; Yi Wang; David K C Cooper; Hayato Iwase
Journal:  Transpl Immunol       Date:  2018-08-06       Impact factor: 1.708

2.  Anti-Neu5Gc and anti-non-Neu5Gc antibodies in healthy humans.

Authors:  Bingsi Gao; Cassandra Long; Whayoung Lee; Zhongqiang Zhang; Xiaotian Gao; Doug Landsittel; Mohamed Ezzelarab; David Ayares; Yuliang Huang; David K C Cooper; Yi Wang; Hidetaka Hara
Journal:  PLoS One       Date:  2017-07-17       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.